Ashley Feneran, DO
Dermatology · Wheaton, ILNPI 1225303407
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $1,414 of the $1,676 with a category attached, or 84.4%. It is spread thinly across 15 manufacturers, the largest accounting for just 15.0% — the pattern of someone who eats at a lot of different presentations. That places this record below the midpoint for dermatology clinicians in IL, where the typical reported total is $1,774.
Across 55 payments — averaging $30.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$251
- Regeneron Healthcare Solutions, Inc.$247
- Johnson & Johnson$234
- Novartis$160
- Sun Pharmaceutical Industries Inc.$150
- Ortho Dermatologics, A Division Of Bausch Health US, LLC$125
- plus $509 from 9 others
What the payments were for
- Food & beverage$1,41484%
- Education$26216%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 15 | $251 |
| Regeneron Healthcare Solutions, Inc. | 5 | $247 |
| Johnson & Johnson | 4 | $234 |
| Novartis | 8 | $160 |
| Sun Pharmaceutical Industries Inc. | 2 | $150 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 1 | $125 |
| LEO Pharma Inc. | 4 | $98 |
| Lilly USA, LLC | 3 | $75 |
| Galderma Laboratories, L.p. | 2 | $74 |
| Pfizer | 4 | $68 |
| Sanofi | 2 | $62 |
| Fresenius Kabi USA, LLC | 2 | $50 |
| UCB, Inc. | 1 | $39 |
| E.r. Squibb & Sons, L.L.C. | 1 | $27 |
| Amgen | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,676 in reported general payments places this provider in the 45th percentile of 606 dermatology providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent PenDupilumab | 24 | $114,439 |
| Ketoconazole | 119 | $3,293 |
| Clobetasol Propionate | 50 | $2,658 |
| Betamethasone Diprop AugmentedBetamethasone/Propylene Glyc | 59 | $2,083 |
| Doxycycline Hyclate | 39 | $1,222 |
| Fluorouracil | 18 | $1,192 |
| Metronidazole | 24 | $1,185 |
| Triamcinolone Acetonide | 71 | $814 |
| Tacrolimus | 12 | $785 |
| Ciclopirox | 19 | $416 |
| MethotrexateMethotrexate Sodium | 17 | $296 |
| Minoxidil | 21 | $175 |
| Mupirocin | 21 | $130 |
| Cephalexin | 14 | $49 |
| Hydrocortisone | 16 | $45 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Wheaton
- James HerrmannWheaton$320K
- Ahmad AminNaperville$4.1M
- Raj ChovatiyaChicago$3.6M
- George LewittNorthbrook$3M
- Peter LioChicago$2.4M
- Elizabeth KiracofeChicago$1.6M
- Lana SchmidtEffingham$1.3M
- Melissa AbramsVernon Hills$600K
- Carolyn JacobChicago$566K
- Walter LiszewskiChicago$414K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.